Differences in response of thyrotropin to 3,5,3′-triiodothyronine and 3,5,3′-triiodothyroacetic acid in patients with resistance to thyroid hormone

Thyroid

Volumn 6, Issue 6, 1996, Pages 563-570

  Ueda, Shin ^a   Takamatsu, Junta ^a   Fukata, Shuji ^b   Tanaka, Koshi ^c   Shimizu, Naokata ^c   Sakata, Shigeki ^d   Yamaji, Tohru ^e   Kuma, Kanji ^b   Ohsawa, Nakaaki ^a  

^a OSAKA MEDICAL COLLEGE   (Japan)

^b KUMA HOSPITAL   (Japan)

^c TEIKYO UNIVERSITY   (Japan)

^d Joto Clinic of Internal Medicine

^e UNIVERSITY OF TOKYO   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

3,3',5-TRIIODOTHYROACETIC ACID; DRUG DERIVATIVE; FERRITIN; LIOTHYRONINE; SEX HORMONE BINDING GLOBULIN; THYROTROPIN; TIRATRICOL;

ADENOMA; ADOLESCENT; ALPHA CHAIN; ARTICLE; BLOOD; FEMALE; HUMAN; HYPOPHYSIS TUMOR; MALE; METABOLISM; MIDDLE AGED; PATHOPHYSIOLOGY; PRESCHOOL CHILD; SECRETION; THYROID GLAND; THYROID HORMONE RESISTANCE;

ADENOMA; ADOLESCENT; CHILD, PRESCHOOL; FEMALE; FERRITINS; GLYCOPROTEIN HORMONES, ALPHA SUBUNIT; HUMANS; MALE; MIDDLE AGED; PITUITARY NEOPLASMS; SEX HORMONE-BINDING GLOBULIN; THYROID GLAND; THYROID HORMONE RESISTANCE SYNDROME; THYROTROPIN; TRIIODOTHYRONINE;

EID: 0030331533     PISSN: 10507256     EISSN: None     Source Type: Journal    
DOI: 10.1089/thy.1996.6.563     Document Type: Article

References (22)

1. Refetoff S, Weiss RE, Usala SJ 1993 The syndromes of resistance to thyroid hormone. Endocr Rev 14:348-399.
2. Hayashi Y, Weiss RE, Same DH, Yen PM, Sunthornthepvarakul T, Marcocci C, Chin WW, Refetoff S 1995 Do clinical manifestations of resistance to thyroid hormone correlate with the functional alteration of the corresponding mutant thyroid hormone-β receptors? J Clin Endocrinol Metab 80:3246-3256.
3. Beck-Peccoz P, Sartorio A, De Medici C, Grugni G, Morabito F, Faglia G 1988 Dissociated thyromimetic effects of 3,5,3′-triiodothyroacetic acid (TRIAC) at the pituitary and peripheral tissue levels. J Endocrinol Invest 11:113-118.
4. Menegay C, Juge C, Burger G 1989 Pharmacokinetics of 3,5,3′-triiodothyroacetic acid and its effects on serum TSH levels. Acta Endocrinol (Copenh) 121:651-658.
5. Beck-Peccoz P, Piscitelli G, Cattaneo MG, Faglia G 1983 Successful treatment of hyperthyroidism due to non-neoplastic pituitary TSH hypersecretion with 3,5,3′-triiodothyroacetic acid (TRIAC). J Endocrinol Invest 6:217-223.
6. Salmela PI, Wide L, Juustila H, Ruokonen A 1988 Effects of thyroid hormones (T4, T3), bromocriptine and TRIAC on in-appropriate TSH hypersecretion. Clin Endocrinol (Oxf) 28:497-507.
7. Kunitake JM, Hartman N, Henson LC, Lieberman J, Williams DE, Wong M, Hershman JM 1989 3,5,3′-triiodothyroacetic acid therapy for thyroid hormone resistance. J Clin Endocrinol Metab 69:461-466.
8. Dulgeroff AJ, Geffner ME, Koyal SN, Wong M, Hershman JM 1992 Bromocriptine and Triac therapy for hyper thyroidism due to pituitary resistance to thyroid hormone. J Clin Endocrinol Metab 75:1071-1075.
9. Takeda T, Suzuki S, Liu R, DeGroot LJ 1995 Triiodothyroacetic acid has unique potential for therapy of resistance to thyroid hormone. J Clin Endocrinol Metab 80:2033-2040.
10. Same DH, Refetoff S, Rosenfield RL, Farriaux JP 1988 Sex hormone-binding globulin in the diagnosis of peripheral tissue resistance to thyroid hormone: The value of changes after short-term triiodothyronine administration. J Clin Endocrinol Metab 66:740-746.
11. Beck-Peccoz P, Roncoroni R, Mariotti S, Medri G, Marcocci C, Brabant G, Forloni F, Pinchera A, Faglia G 1990 Sex hormone-binding globulin measurement in patients with inappropriate secretion of thyrotropin (IST): Evidence against selective pituitary thyroid hormone resistance in nonneoplastic IST. J Clin Endocrinol Metab 71:19-25.
12. Takamatsu J, Majima M, Miki K, Kuma K, Mozai T 1985 Serum ferritin as a marker of thyroid hormone action on peripheral tissues. J Clin Endocrinol Metab 61:672-676.
13. Kourides IA, Weintraub BD, Rosen SW, Ridgway EC, Kliman B, Maloof F 1976 Secretion of alpha subunit of glycoprotein hormones by pituitary adenomas. J Clin Endocrinol Metab 43:97-106.
14. Ishibashi M, Yamaji T, Takaku F, Teramoto A, Fukushima T 1987 Secretion of glycoprotein hormone α-subunit by pituitary tumors. J Clin Endocrinol Metab 64:1187-1193.
15. Takamatsu J, Mozai T, Kuma K 1984 Bromocriptine therapy for hyperthyroidism due to increased thyrotropin secretion. J Clin Endocrinol Metab 58:934-936.
16. Takamatsu J, Miki K, Isaji H, Kitazawa A, Furukawa K, Fujiwara M, Kuma K 1984 Resistance of peripheral tissues and pituitary to thyroid hormone. Endocrinol Japon 31:435-441.
17. Tsukaguchi H, Yoshimasa Y, Fujimoto K, Ishii H, Yamamoto T, Yoshimasa T, Yagura T, Takamatsu J 1995 Three novel mutations of thyroid hormone receptor β gene in unrelated patients with resistance to thyroid hormone: Two mutations of same codon (H435L and H435Q) produce separate subtypes of resistance. J Clin Endocrinol Metab 80:3613-3616.
18. Onigata K, Yagi H, Sakurai A, Nagashima T, Nomura Y, Nagashima K, Hashizume K, Morikawa A 1995 A novel point mutation (R243Q) in exon 7 of the c-erbA beta thyroid hormone receptor gene in a family with resistance to thyroid hormone. Thyroid 5:355-358.
19. Lieblich J, Utiger RD 1972 Triiodothyronine radioimmunoassay. J Clin Invest 51:157-166.
20. 3CT). Proceedings of the 77th Meeting of the Endocrine Society: 211 (P1-396, Abstract).
21. Oppenheimer DS 1991 TSH-and other glycoprotein-producing pituitary adenomas: Alpha-subunit as a tumor marker. Thyroid Today 14:1-11.
22. Persani L, Asteria C, Tonacchera M, Vitti P, Chatterjee VKK, Beck-Peccoz P 1994 Evidence for the secretion of thyrotropin with enhanced bioactivity in syndrome of thyroid hormone resistance. J Clin Endocrinol Metab 78:1034-1039.